270 related articles for article (PubMed ID: 21203561)
1. The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling.
Drafahl KA; McAndrew CW; Meyer AN; Haas M; Donoghue DJ
PLoS One; 2010 Dec; 5(12):e14412. PubMed ID: 21203561
[TBL] [Abstract][Full Text] [Related]
2. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
3. IL-1β inhibits β-Klotho expression and FGF19 signaling in hepatocytes.
Zhao Y; Meng C; Wang Y; Huang H; Liu W; Zhang JF; Zhao H; Feng B; Leung PS; Xia Y
Am J Physiol Endocrinol Metab; 2016 Feb; 310(4):E289-300. PubMed ID: 26670488
[TBL] [Abstract][Full Text] [Related]
4. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
[TBL] [Abstract][Full Text] [Related]
5. G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα.
Patial S; Luo J; Porter KJ; Benovic JL; Parameswaran N
Biochem J; 2009 Dec; 425(1):169-78. PubMed ID: 19796012
[TBL] [Abstract][Full Text] [Related]
6. Kelch-like Protein 21 (KLHL21) Targets IκB Kinase-β to Regulate Nuclear Factor κ-Light Chain Enhancer of Activated B Cells (NF-κB) Signaling Negatively.
Mei ZZ; Chen XY; Hu SW; Wang N; Ou XL; Wang J; Luo HH; Liu J; Jiang Y
J Biol Chem; 2016 Aug; 291(35):18176-89. PubMed ID: 27387502
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor 19-Mediated Up-regulation of SYR-Related High-Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms-Related Tyrosine Kinase 4.
Chen J; Du F; Dang Y; Li X; Qian M; Feng W; Qiao C; Fan D; Nie Y; Wu K; Xia L
Hepatology; 2020 May; 71(5):1712-1731. PubMed ID: 31529503
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling.
Pai R; Dunlap D; Qing J; Mohtashemi I; Hotzel K; French DM
Cancer Res; 2008 Jul; 68(13):5086-95. PubMed ID: 18593907
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation allows integration of multiple signaling inputs by IKKβ.
Meyer AN; Drafahl KA; McAndrew CW; Gilda JE; Gallo LH; Haas M; Brill LM; Donoghue DJ
PLoS One; 2013; 8(12):e84497. PubMed ID: 24386391
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation.
Cárcamo JM; Pedraza A; Bórquez-Ojeda O; Golde DW
Biochemistry; 2002 Oct; 41(43):12995-3002. PubMed ID: 12390026
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
Hu L; Cong L
Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.
Tiong KH; Tan BS; Choo HL; Chung FF; Hii LW; Tan SH; Khor NT; Wong SF; See SJ; Tan YF; Rosli R; Cheong SK; Leong CO
Oncotarget; 2016 Sep; 7(36):57633-57650. PubMed ID: 27192118
[TBL] [Abstract][Full Text] [Related]
14. Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression.
Lang L; Shull AY; Teng Y
Curr Cancer Drug Targets; 2019; 19(1):17-25. PubMed ID: 29557750
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor 3 interacts with and activates TGFβ-activated kinase 1 tyrosine phosphorylation and NFκB signaling in multiple myeloma and bladder cancer.
Salazar L; Kashiwada T; Krejci P; Meyer AN; Casale M; Hallowell M; Wilcox WR; Donoghue DJ; Thompson LM
PLoS One; 2014; 9(1):e86470. PubMed ID: 24466111
[TBL] [Abstract][Full Text] [Related]
16. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase.
Zhang L; Cui R; Cheng X; Du J
Cancer Res; 2005 Jan; 65(2):457-64. PubMed ID: 15695387
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
[TBL] [Abstract][Full Text] [Related]
18. TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.
Bonif M; Meuwis MA; Close P; Benoit V; Heyninck K; Chapelle JP; Bours V; Merville MP; Piette J; Beyaert R; Chariot A
Biochem J; 2006 Mar; 394(Pt 3):593-603. PubMed ID: 16336209
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.
Sanlioglu S; Williams CM; Samavati L; Butler NS; Wang G; McCray PB; Ritchie TC; Hunninghake GW; Zandi E; Engelhardt JF
J Biol Chem; 2001 Aug; 276(32):30188-98. PubMed ID: 11402028
[TBL] [Abstract][Full Text] [Related]
20. Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.
Higashimoto T; Chan N; Lee YK; Zandi E
J Biol Chem; 2008 Dec; 283(51):35354-67. PubMed ID: 18957422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
